- Home
- RBA vs SLRX Comparison
RBA vs SLRX Comparison
Compare RBA & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RBA
- SLRX
- Stock Information
- Founded
- RBA 1958
- SLRX N/A
- Country
- RBA United States
- SLRX United States
- Employees
- RBA N/A
- SLRX N/A
- Industry
- RBA Business Services
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- RBA Consumer Discretionary
- SLRX Health Care
- Exchange
- RBA Nasdaq
- SLRX Nasdaq
- Market Cap
- RBA 19.7B
- SLRX 1.8M
- IPO Year
- RBA 1998
- SLRX N/A
- Fundamental
- Price
- RBA $107.97
- SLRX $0.75
- Analyst Decision
- RBA Buy
- SLRX
- Analyst Count
- RBA 6
- SLRX 0
- Target Price
- RBA $111.42
- SLRX N/A
- AVG Volume (30 Days)
- RBA 938.2K
- SLRX 3.6M
- Earning Date
- RBA 08-06-2025
- SLRX 08-08-2025
- Dividend Yield
- RBA 1.08%
- SLRX N/A
- EPS Growth
- RBA 22.04
- SLRX N/A
- EPS
- RBA 2.03
- SLRX N/A
- Revenue
- RBA $4,328,100,000.00
- SLRX N/A
- Revenue This Year
- RBA $4.62
- SLRX N/A
- Revenue Next Year
- RBA $4.06
- SLRX N/A
- P/E Ratio
- RBA $53.27
- SLRX N/A
- Revenue Growth
- RBA 2.27
- SLRX N/A
- 52 Week Low
- RBA $70.38
- SLRX $0.45
- 52 Week High
- RBA $109.25
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- RBA 63.00
- SLRX 41.73
- Support Level
- RBA $103.56
- SLRX $0.66
- Resistance Level
- RBA $105.97
- SLRX $0.90
- Average True Range (ATR)
- RBA 1.83
- SLRX 0.12
- MACD
- RBA 0.18
- SLRX -0.03
- Stochastic Oscillator
- RBA 91.23
- SLRX 16.46
About RBA RB Global Inc.
RB Global operates the world's largest auction for heavy equipment. The company started as a live auctioneer of industrial equipment; since then it has greatly expanded its operations to include the sale of construction, agricultural, oilfield, and transportation equipment. RB Global operates over 40 live auction sites in more than 12 countries, along with online marketplaces, including IronPlanet, Marketplace-E, and GovPlanet. Its agricultural auctions are frequently much smaller venues and can include liquidations of single farms. The company holds over 300 auctions yearly and sells $6 billion worth of equipment.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.